Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First patient with ovarian cancer dosed in second phase I study of Radspherin

June 12, 2020

Estrogen precursor drives breast cancer in obese postmenopausal women

June 12, 2020

Oncometabolites mask DNA repair signals

June 12, 2020

Actuate Therapeutics begins pediatric phase I study of 9-ING-41 for refractory malignancies

June 11, 2020

Cleave begins phase I study of CB-5339 in relapsed/refractory AML and MDS

June 11, 2020

Merck & Co. describes new adenosine receptor antagonists

June 11, 2020

Exon-intron fusions play role in osteosarcoma metastases

June 11, 2020

U.K. researchers present BCL-6 inhibitors

June 11, 2020

Dana-Farber Cancer Institute and Voronoi patent DYRK1A inhibitors

June 11, 2020

NLRP3 inhibitors presented by Novartis Inflammasome Research

June 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...